Salveo Capital

2015

Founded

23

Investments

United States

Offices

Venture Fund

Investor Type

About

Salveo Capital is a venture capital firm dedicated to supporting high-growth businesses within the legal cannabis industry. Established in 2016, the firm focuses on companies that provide ancillary products and services, including financial services, ag-tech, software, bio-pharma, and business services. Salveo Capital aims to build long-term sustainable companies that will reshape the image of legal cannabis and contribute to a vibrant market.

The firm partners with entrepreneurs who have the vision and drive to bring innovative ideas to life, offering both capital and strategic support. Additionally, Salveo Capital invests in technologies, products, and services that address the unique requirements of the cannabis industry, fostering innovation and growth.

Investment Focus

Investment Stage

HQ Locations

Portfolio Companies

Fyllo, PathogenDx, Front Range Biosciences, KelSie Biotech, Wurk, Harborside, Flow Kana

Gepgraphic Focus

United States

Key Differentiators

Institutional quality discipline in company vetting, investment structures, and portfolio management, Focus on building long-term sustainable companies in the legal cannabis industry, Active partnership with entrepreneurs beyond capital investment, Support for innovative technologies and services addressing unique industry requirements

Thypical Investment Size

Not publicly disclosed

Total Funds Raised

Not publicly disclosed

Visit Website

Software

Seed

Series A

Series B

United States